Sars-cov-2 variants, rbd mutations, binding affinity, and antibody escape

Immunology and Microbiology

• Binding Antibody 100%
• Binding Affinity 100%
• Monospecific Antibody 80%
• Receptor Binding 80%
• Vaccine Efficacy 40%
• Breakthrough Infection 40%
• Severe Acute Respiratory Syndrome Coronavirus 2 40%
• Spike 40%
• COVID-19 20%
• Vaccination Policy 20%
• Face 20%
• Binding Site 20%
• Missense Mutation 20%
• Coronavirus 20%
• Therapeutic Antibodies 20%
• Induced Mutation 20%

Biochemistry, Genetics and Molecular Biology

• Binding Affinity 100%
• Monospecific Antibody 80%
• Binding Domain 80%
• Receptor Binding 80%
• Spike 40%
• SARS Coronavirus 40%
• Amino Acids 20%
• Binding Site 20%
• Eicosanoid Receptor 20%
• Missense Mutation 20%
• Induced Mutation 20%
• Coronavirinae 20%
• Binding Energy 20%
• Therapeutic Antibodies 20%
• Angiotensin-Converting Enzyme 2 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Receptor 100%
• Infection 40%
• SARS Coronavirus 40%
• Disease 20%
• Amino Acid 20%
• Vaccination Policy 20%
• Binding Site 20%
• Coronavirinae 20%
• Angiotensin Converting Enzyme 2 20%
• Delta Variant 20%